This article waslast modified
on September 10, 2018.
Laboratories use a variety of methodologies to test the countless analytes that are of interest to the medical community. Understanding the method used for a test provides a broader context for understanding your test results. Below are explanations of several common laboratory methods mentioned on this site.
Laboratory methods are based on established scientific principles involving biology, chemistry, and physics, and encompass all aspects of the clinical laboratory from testing the amount of cholesterol in your blood to analyzing your DNA to growing microscopic organisms that may be causing an infection. Such methods are much like the recipes in a cookbook, defining the procedures or processes that are used to test biological samples for particular analytes or substances. The laboratory scientist follows step-by-step procedures until the end product, a test result, is achieved.
Some methods, like some recipes, are much more complicated and labor-intensive than others and require varying degrees of expertise. Often, there may be more than one method that can be used to test for the same substance. Consequently, the same analyte may be tested differently in different laboratories, a fact that is crucial when comparing test results.
The descriptions of the methods listed below attempt to give some insight into the scientific principles used and the steps that are required to produce a result. Explanations of the methods – and their differences – are provided to give you a better understanding of some of the tests that you may undergo. These items are not intended to be a comprehensive list of available methodologies, but do represent some of those that are mentioned on this web site.
Immunoglobulins are proteins produced by the immune system to recognize, bind to, and neutralize foreign substances in the body. Immunoassays are tests based on the very specific binding that occurs between an immunoglobulin (called an antibody) and the substance that it specifically recognizes (the foreign molecule, called an antigen). Immunoassays can be used to test for the presence of a specific antibody or a specific antigen in blood or other fluids.
When immunoassays are used to test for the presence of an antibody in a blood or fluid sample, the test contains the specific antigen as part of the detection system. If the antibody being tested for is present in the sample, it will react with or bind to the antigen in the test system and will be detected as positive. If there is no significant reaction, the sample tests negative. Examples of immunoassay tests for antibodies include rheumatoid factor (which tests for the presence of autoimmune antibodies seen in patients with rheumatoid arthritis), West Nile virus (which tests for antibodies that a person made in response to an infection with that virus) or antibodies made in response to a vaccination (such as tests for antibodies to hepatitis B to assure that the vaccination was successful).
When immunoassays are used to test for the presence of antigens in a blood or fluid sample, the test contains antibodies to the antigen of interest. The reaction of the antigen that is present in the person's sample to the specific antibody is compared with reactions of known concentrations and the amount of antigen is reported. Examples of immunoassay tests for antigens include drug levels (like digoxin, vancomycin), hormone levels (like insulin, TSH, estrogen), and cancer markers (like PSA, CA-125, and AFP).
This testing method is a type of immunoassay. It is based on the principle that antibodies will bind to very specific antigens to form antigen-antibody complexes, and enzyme-linked antigens or antibodies can be used to detect and measure these complexes.
To detect or measure an antibody in a person's blood, a known antigen is attached to a solid surface. A solution containing the patient sample is added. If the patient's sample contains antibody, it will bind to the antigen. A second antibody (against human antibodies) that is labeled with an enzyme is then added. If the enzyme-linked antibody binds to human antibodies, the enzyme will create a detectable change that indicates the presence and amount of the antibody in the patient sample.
(2001). Gerostamoulos, J. et. al. (2001). The Use Of Elisa (Enzyme-Linked Immunosorbent Assay) Screening In Postmortem Blood. TIAFT, The International Association of Forensic Toxicologists [On-line information]. Available online at http://www.tiaft.org/tiaft2001/lectures/l13_gerostamoulos.doc.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Harris, N. and Winter, W.
This is an immunoassay test method that detects specific proteins in blood or tissue. It combines an electrophoresis step with a step that transfers (blots) the separated proteins onto a membrane. Western blot is often used as a follow-up test to confirm the presence of an antibody and to help diagnose a condition. An example of its use includes Lyme disease testing.
To perform a western blot test, a sample containing the protein is applied to a spot along one end of a layer of gel. Multiple samples and a control may be placed side by side along one end of the gel in separate "lanes." An electrical current causes the proteins in the sample(s) to move across the gel, separating the proteins by size and shape and forming bands that resemble the steps of a ladder. These sample and control ladders are then "blotted" (transferred) onto a thin membrane that is put in contact with the gel. Labelled or tagged antibodies are then used in a one or two step process to detect the proteins bound to the membrane. For example, to confirm HIV or Lyme antibody tests, the proteins separated are those of the causative organism. A patient’s sample is then added to the blot and any antibodies to the organism are bound and later detected by labeled antibodies to human immunoglobulins. The presence of the certain proteins is interpreted by comparison with known negative or positive control samples in the other lanes.
Khalsa, G. Western blotting. Arizona State University, School of Life Sciences, Mama Ji's Molecular Kitchen [On-line information]. Available online at http://lifesciences.asu.edu/resources/mamajis/western/western.html.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA and Ashwood ER, Bruns DE, eds. 4th edition St. Louis: Elsevier Saunders; 2006.
This molecular testing method uses fluorescent probes to evaluate genes and/or DNA sequences on chromosomes.
Humans normally have 23 pairs of chromosomes: 22 pairs of non-sex-determining chromosomes (autosomes) and 1 pair of sex chromosomes (XX for females and XY for males). Chromosomes are made up of DNA, repeating sequences of four bases that form the thousands of genes that direct protein production in the body and determine our physical characteristics. DNA consists of two strands bound together in a double helix structure (like a spiral staircase). Each half of the helix is a complement of the other.
For a FISH test, a sample of a person's cells containing DNA is fixed to a glass slide. Samples can include blood, bone marrow, amniotic fluid, or tumor cells, depending on the clinical indication. The slides with the "target" (person's) DNA are heated to separate the double strands of DNA into single strands. Fluorescent probes are then added to the sample. Fluorescent probes are sections of single-stranded DNA that are complementary to the specific portions of DNA of interest. The probe, which is labeled with a fluorescent dye, attaches to the specific piece of DNA. When the slides are examined using a special microscope, the genes that match the probe can be seen as areas of fluorescence, which will appear as bright spots on a dark background.
This technique can be used to show the presence of extra gene copies (duplicated or amplified genes), and genetic sequences that are missing (gene deletions) or have been moved (translocated genes). Increased numbers of chromosomes, as seen in certain genetic disorders, are also diagnosed using FISH technologies (trisomy 21 or Down syndrome, for example). The targeted area(s) or sequences of DNA are determined by the probes that are used. Multiple targeted areas in the DNA can be assessed at the same time using FISH probes labeled with a number of different fluorescent dyes.
The following photographs show cells that have been evaluated using the FISH methodology. These are just a few examples of the use of FISH technique.
In Figure 1, FISH testing is applied to cells in amniotic fluid, obtained from a pregnant woman carrying a baby suspected of having Down syndrome (trisomy 21). Three copies of chromosome 21 are observed (red signals). The green signals (two copies) are for chromosome 13; these are for control purposes and show that the test is working properly. FISH supports a clinical diagnosis of trisomy 21. The doctors and genetic counselors will work with the woman to help her understand the results of the test.
In Figure 2, FISH is used to assess breast tumor cells for the presence of an amplified gene, HER-2/neu (red signals). In approximately 25% of breast cancers, HER-2/neu is amplified. Women with amplified HER-2/neu tumors are treated with a drug (Herceptin) that targets the protein that is the product of the abnormal gene. If a woman is NOT positive for HER-2/neu amplification, she is not likely to receive any therapeutic benefit from Herceptin therapy and other drugs are considered.
Figure 3 shows FISH used in a particular type of chronic leukemia, chronic myelogenous leukemia (CML). The specific probes used in this case detect BCR-ABL, an abnormal gene sequence formed by the translocation of a portion of chromosome 22 (BCR, a green probe) with a portion of chromosome 9 (ABL1, a red probe). The areas of yellow fluorescence signify the abnormal, fusion gene (joining of red and green probes). Finding the BCR-ABL fusion confirms a diagnosis of CML. BCR-ABL positive patients receive benefit from molecular-targeted drugs, such as imatinib.
(August 16, 2010) Fluorescence In Situ Hybridization (FISH). National Human Genome Research Institute [On-line information]. Available online at http://www.genome.gov/10000206. Accessed March 2011.
(August 16, 2010) Frequently Asked Questions about Genetic Testing. National Human Genome Research Institute [On-line information].Available online at http://www.genome.gov/19516567. Accessed March 2011.
(March 6, 2006) Genetics Home Reference. Fluorescent in situ hybridization. Available online at http://ghr.nlm.nih.gov/glossary=fluorescentinsituhybridization. Accessed March 2011.
(June 29, 2011) Hiller B, Bradtke J, Balz H and Rieder H (2004). CyDAS Online Analysis Site. Available online at http://www.cydas.org/OnlineAnalysis/. Accessed July 2011.
PCR is a laboratory method used for making a very large number of copies of short sections of DNA from a very small sample of genetic material. This process is called "amplifying" the DNA and it enables specific genes of interest to be detected or measured.
DNA is made up of repeating sequences of four bases – adenine, thymine, guanine, and cytosine. These sequences form two strands that are bound together in a double helix structure by hydrogen bonds (like a spiral staircase). Each half of the helix is a complement of the other. In humans, it is the difference in the sequence of these bases on each strand of DNA that leads to the uniqueness of each person's genetic makeup. The arrangement of the bases in each gene is used to produce RNA, which in turn produces a protein. There are about 25,000 genes in a human genome, and expression of these genes leads to the production of a large number of proteins that make up our bodies. The DNA of other organisms such as bacteria and viruses is also composed of thousands of different genes that code for their proteins.
How is the method performed?
PCR is carried out in several steps or "cycles" in an instrument called a thermocycler. This instrument increases and decreases the temperature of the specimen at defined intervals during the procedure.
The first step or cycle of PCR is to separate the strands of DNA into two single strands by increasing the temperature of the sample that contains the DNA of interest. This is called "denaturing" the DNA.
Once the strands separate, the sample is cooled slightly and forward and reverse primers are added and allowed to bind to the single DNA strands. Primers are short sequences of bases made specifically to recognize and bind to the section of DNA to be amplified, which are the very specific sequence of bases that are part of the gene or genes of interest. Primers are called "forward" and "reverse" in reference to the direction that the bases within the section of DNA are copied.
After the two primers attach to each strand of the DNA, a DNA enzyme (frequently Taq polymerase) then copies the DNA sequence on each half of the helix from the forward to the reverse primer, forming two double stranded sections of DNA, each with one original half and one new half. Taq polymerase is an enzyme found in a bacterium (Thermues aquaticus) that grows in very hot water, such as in geysers or hot springs. Polymerases copy DNA (or RNA) to make new strands. The Taq polymerase is especially helpful for laboratory testing because (unlike many other enzymes) it does not break down at very high temperatures needed to do PCR.
When heat is applied again, each of the two double strands separate to make four single strands and, when cooled, the primers and polymerase act to make four double strand sections. The four strands becomes eight in the next cycle, eight become sixteen, and so on.
Within 30 to 40 cycles, as many as a billion copies of the original DNA section can be produced and are then available to be used in numerous molecular diagnostic tests. This process has been automated so that a billion copies of the original DNA can be produced within a few hours.
How is it used?
This method can be used, for example, to detect certain genes in a person's DNA, such as those associated with cancer or genetic disorders, or it may be used to detect genetic material of bacteria or viruses that are causing an infection.
These are just a few examples of laboratory tests that use PCR:
Real-time PCR is similar to PCR except that data are obtained as the amplification process is taking place (i.e., "real time") rather than at a prescribed endpoint and shortens the time for the test from overnight to a few hours. This method is used to measure the amount of DNA that is present in a sample.
RT-PCR (Reverse Transcriptase PCR)
This method uses PCR to amplify RNA. RNA is a single stranded nucleic acid molecule and needs to be made into DNA before it can be amplified. The addition of a new strand that is the complement of RNA is achieved by the enzyme called Reverse Transcriptase (RT) and an antisense (reverse) primer. The primer binds to the single stranded RNA and the enzyme RT copies the RNA strand to make a single stranded DNA, which it then copies to make a double stranded DNA molecule. The double stranded molecule can now be amplified by PCR. Detection can also be by real-time methods.
Here are two examples of laboratory tests that use RT-PCR:
Flow cytometry is a laboratory method used to detect, identify, and count specific cells. This method can also identify particular components within cells. This information is based on physical characteristics and/or markers called antigens on the cell surface or within cells that are unique to that cell type. This method may be used to evaluate cells from blood, bone marrow, body fluids such as cerebrospinal fluid (CSF), or tumors.
How is it performed?
Flow cytometry involves several steps:
A sample of cells is suspended in a fluid.
Prior to testing and depending on the cells being analyzed, the sample may be treated with special dyes to further define cell sub-types. The dyes (fluorochromes) that are used are attached to monoclonal antibodies that bind to particular cells or key components of cells.
The sample containing the cells passes through an instrument called a flow cytometer.
In the instrument, the fluid in which the cells are suspended passes through very narrow channels so that the cells are organized in a single file as they pass the detector(s). This is accomplished at a high rate of speed (hundreds to thousands of cells per second.)
The flow cytometer contains one or more lasers and a series of photo detectors that are able to identify certain characteristics unique to various cell types. The single-cell suspension creates unique light-scattering events that occur when each cell passes through the laser light. These initial events are characteristic of the size and shape of the cell, as well as the intensity of the signal that is generated by the specific dyes, thus creating patterns that reflect cell type.
The signals from the detectors are amplified and sent to a computer. They are converted to digital read-outs displayed on a computer screen or in a printout.
The data are usually displayed as graphs.
This analysis allows evaluation of the types and numbers of cells in the sample. The flow cytometer is sensitive enough to analyze cells or particles as small as one micron in diameter (about the size of 1/75th of a human hair) and can be performed on relatively small sample sizes. Thousands of cells can be counted and analyzed in a few minutes, providing a highly accurate picture of any tissue or body fluid's cellular composition.
One additional function of a flow cytometer is the ability to physically separate unique cell types based on the characteristics mentioned above. Once a sample has passed through the laser light and photo detectors, an electric charge can be applied to the cells of interest. This occurs when a fluid sample is broken into droplets that are positively or negatively electrically charged and then deflected by oppositely-charged deflection plates. The cells of interest can then be physically collected into separate vessels for further testing.
How is it used?
Flow cytometry has been available for several decades and been adapted for use in many areas of clinical testing. Below are just a few examples of tests described on this site that use flow cytometry:
Flow cytometry has been applied in identifying various cell types unique to certain diseases. One of the most common is in the diagnosis of blood-related cancers such as leukemia and lymphoma. Very specific monoclonal antibodies that have been treated with a fluorochrome are utilized to detect the presence or absence of various cellular components that are commonly seen in certain types of cancers. This information is used in the diagnosis, prognosis, and treatment of these diseases. This is especially useful in the early stages of a malignant disease where there may be only a few cancer cells present in the sample and these could go undetected by ordinary examination under a microscope.
Brown M, Wittwer C. Flow Cytometry: Principles and Clinical Applications in Hematology. Clinical Chemistry 46:8(B) 1221–1229 (2000). Available online at http://clinchem.aaccjnls.org/content/46/8/1221.
Craig F E and Foon KA (2008). Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111:3941-3967.
Kern W., et.al, (2008) Monitoring of minimal residual disease in acute myeloid leukemia. Cancer 112:4-16.
Basic Information on Flow Cytometry [17 paragraphs] Flow Cytometry Facility, University of California, Berkeley [On-line information]. Accessed on: 7/28/07 Available online at http://biology.berkeley.edu/crl/flow_cytometry_basic.pdf.
Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. McPherson R, Pincus M, eds. Philadelphia, PA: Saunders Elsevier: 2011. 48-49, 656-660.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Nader Rifai, ed; senior editors, Andrea R. Horvath, Carl T. Wittwer., St. Louis, Missouri: Elsevier Saunders; 2018. Chap 25.